Global Polio Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
According to APO Research, The global Polio Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Polio Vaccine include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Polio Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polio Vaccine.
The Polio Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polio Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polio Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Polio Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
According to APO Research, The global Polio Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Polio Vaccine include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Polio Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polio Vaccine.
The Polio Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Polio Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Sanofi
- GSK
- Bibcol
- Serum Institute
- Tiantan Biological
- IMBCA
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- Inactivated Polio Vaccine (IPV)
- Oral Polio Vaccine (OPV)
- Public
- Private
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polio Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Polio Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Polio Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Polio Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Polio Vaccine Market by Type
1.3.1 Inactivated Polio Vaccine (IPV)
1.3.2 Oral Polio Vaccine (OPV)
1.4 Global Polio Vaccine Market Size by Type
1.4.1 Global Polio Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Polio Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Polio Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Polio Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Polio Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Polio Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Polio Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Polio Vaccine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Polio Vaccine Industry Trends
2.2 Polio Vaccine Industry Drivers
2.3 Polio Vaccine Industry Opportunities and Challenges
2.4 Polio Vaccine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Polio Vaccine Revenue (2019-2024)
3.2 Global Top Players by Polio Vaccine Sales (2019-2024)
3.3 Global Top Players by Polio Vaccine Price (2019-2024)
3.4 Global Polio Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Polio Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Polio Vaccine Company, Product Type & Application
3.7 Global Polio Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Polio Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Polio Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Polio Vaccine Tier 1, Tier 2, and Tier
4 POLIO VACCINE REGIONAL STATUS AND OUTLOOK
4.1 Global Polio Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Polio Vaccine Historic Market Size by Region
4.2.1 Global Polio Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Polio Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Polio Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Polio Vaccine Forecasted Market Size by Region
4.3.1 Global Polio Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Polio Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Polio Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 POLIO VACCINE BY APPLICATION
5.1 Polio Vaccine Market by Application
5.1.1 Public
5.1.2 Private
5.2 Global Polio Vaccine Market Size by Application
5.2.1 Global Polio Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Polio Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Polio Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Polio Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Polio Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Polio Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Polio Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Polio Vaccine Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Sanofi
6.1.1 Sanofi Comapny Information
6.1.2 Sanofi Business Overview
6.1.3 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Polio Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments
6.2 GSK
6.2.1 GSK Comapny Information
6.2.2 GSK Business Overview
6.2.3 GSK Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Polio Vaccine Product Portfolio
6.2.5 GSK Recent Developments
6.3 Bibcol
6.3.1 Bibcol Comapny Information
6.3.2 Bibcol Business Overview
6.3.3 Bibcol Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bibcol Polio Vaccine Product Portfolio
6.3.5 Bibcol Recent Developments
6.4 Serum Institute
6.4.1 Serum Institute Comapny Information
6.4.2 Serum Institute Business Overview
6.4.3 Serum Institute Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Serum Institute Polio Vaccine Product Portfolio
6.4.5 Serum Institute Recent Developments
6.5 Tiantan Biological
6.5.1 Tiantan Biological Comapny Information
6.5.2 Tiantan Biological Business Overview
6.5.3 Tiantan Biological Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tiantan Biological Polio Vaccine Product Portfolio
6.5.5 Tiantan Biological Recent Developments
6.6 IMBCA
6.6.1 IMBCA Comapny Information
6.6.2 IMBCA Business Overview
6.6.3 IMBCA Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 IMBCA Polio Vaccine Product Portfolio
6.6.5 IMBCA Recent Developments
6.7 Panacea Biotec Ltd
6.7.1 Panacea Biotec Ltd Comapny Information
6.7.2 Panacea Biotec Ltd Business Overview
6.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
6.7.5 Panacea Biotec Ltd Recent Developments
6.8 Bio-Med
6.8.1 Bio-Med Comapny Information
6.8.2 Bio-Med Business Overview
6.8.3 Bio-Med Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bio-Med Polio Vaccine Product Portfolio
6.8.5 Bio-Med Recent Developments
6.9 Halfkin Bio-Pharmaceuticals
6.9.1 Halfkin Bio-Pharmaceuticals Comapny Information
6.9.2 Halfkin Bio-Pharmaceuticals Business Overview
6.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
6.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Polio Vaccine Sales by Country
7.1.1 North America Polio Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Polio Vaccine Sales by Country (2019-2024)
7.1.3 North America Polio Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Polio Vaccine Market Size by Country
7.2.1 North America Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Polio Vaccine Market Size by Country (2019-2024)
7.2.3 North America Polio Vaccine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Polio Vaccine Sales by Country
8.1.1 Europe Polio Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Polio Vaccine Sales by Country (2019-2024)
8.1.3 Europe Polio Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Polio Vaccine Market Size by Country
8.2.1 Europe Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Polio Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Polio Vaccine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Polio Vaccine Sales by Country
9.1.1 Asia-Pacific Polio Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Polio Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Polio Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Polio Vaccine Market Size by Country
9.2.1 Asia-Pacific Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Polio Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Polio Vaccine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Polio Vaccine Sales by Country
10.1.1 Latin America Polio Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Polio Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Polio Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Polio Vaccine Market Size by Country
10.2.1 Latin America Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Polio Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Polio Vaccine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Polio Vaccine Sales by Country
11.1.1 Middle East and Africa Polio Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Polio Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Polio Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Polio Vaccine Market Size by Country
11.2.1 Middle East and Africa Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Polio Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Polio Vaccine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Polio Vaccine Value Chain Analysis
12.1.1 Polio Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Polio Vaccine Production Mode & Process
12.2 Polio Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Polio Vaccine Distributors
12.2.3 Polio Vaccine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Polio Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Polio Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Polio Vaccine Market by Type
1.3.1 Inactivated Polio Vaccine (IPV)
1.3.2 Oral Polio Vaccine (OPV)
1.4 Global Polio Vaccine Market Size by Type
1.4.1 Global Polio Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Polio Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Polio Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Polio Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Polio Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Polio Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Polio Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Polio Vaccine Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Polio Vaccine Industry Trends
2.2 Polio Vaccine Industry Drivers
2.3 Polio Vaccine Industry Opportunities and Challenges
2.4 Polio Vaccine Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Polio Vaccine Revenue (2019-2024)
3.2 Global Top Players by Polio Vaccine Sales (2019-2024)
3.3 Global Top Players by Polio Vaccine Price (2019-2024)
3.4 Global Polio Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Polio Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Polio Vaccine Company, Product Type & Application
3.7 Global Polio Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Polio Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Polio Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Polio Vaccine Tier 1, Tier 2, and Tier
4 POLIO VACCINE REGIONAL STATUS AND OUTLOOK
4.1 Global Polio Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Polio Vaccine Historic Market Size by Region
4.2.1 Global Polio Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Polio Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Polio Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Polio Vaccine Forecasted Market Size by Region
4.3.1 Global Polio Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Polio Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Polio Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 POLIO VACCINE BY APPLICATION
5.1 Polio Vaccine Market by Application
5.1.1 Public
5.1.2 Private
5.2 Global Polio Vaccine Market Size by Application
5.2.1 Global Polio Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Polio Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Polio Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Polio Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Polio Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Polio Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Polio Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Polio Vaccine Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Sanofi
6.1.1 Sanofi Comapny Information
6.1.2 Sanofi Business Overview
6.1.3 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Polio Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments
6.2 GSK
6.2.1 GSK Comapny Information
6.2.2 GSK Business Overview
6.2.3 GSK Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Polio Vaccine Product Portfolio
6.2.5 GSK Recent Developments
6.3 Bibcol
6.3.1 Bibcol Comapny Information
6.3.2 Bibcol Business Overview
6.3.3 Bibcol Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bibcol Polio Vaccine Product Portfolio
6.3.5 Bibcol Recent Developments
6.4 Serum Institute
6.4.1 Serum Institute Comapny Information
6.4.2 Serum Institute Business Overview
6.4.3 Serum Institute Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Serum Institute Polio Vaccine Product Portfolio
6.4.5 Serum Institute Recent Developments
6.5 Tiantan Biological
6.5.1 Tiantan Biological Comapny Information
6.5.2 Tiantan Biological Business Overview
6.5.3 Tiantan Biological Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tiantan Biological Polio Vaccine Product Portfolio
6.5.5 Tiantan Biological Recent Developments
6.6 IMBCA
6.6.1 IMBCA Comapny Information
6.6.2 IMBCA Business Overview
6.6.3 IMBCA Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 IMBCA Polio Vaccine Product Portfolio
6.6.5 IMBCA Recent Developments
6.7 Panacea Biotec Ltd
6.7.1 Panacea Biotec Ltd Comapny Information
6.7.2 Panacea Biotec Ltd Business Overview
6.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
6.7.5 Panacea Biotec Ltd Recent Developments
6.8 Bio-Med
6.8.1 Bio-Med Comapny Information
6.8.2 Bio-Med Business Overview
6.8.3 Bio-Med Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bio-Med Polio Vaccine Product Portfolio
6.8.5 Bio-Med Recent Developments
6.9 Halfkin Bio-Pharmaceuticals
6.9.1 Halfkin Bio-Pharmaceuticals Comapny Information
6.9.2 Halfkin Bio-Pharmaceuticals Business Overview
6.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
6.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Polio Vaccine Sales by Country
7.1.1 North America Polio Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Polio Vaccine Sales by Country (2019-2024)
7.1.3 North America Polio Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Polio Vaccine Market Size by Country
7.2.1 North America Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Polio Vaccine Market Size by Country (2019-2024)
7.2.3 North America Polio Vaccine Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Polio Vaccine Sales by Country
8.1.1 Europe Polio Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Polio Vaccine Sales by Country (2019-2024)
8.1.3 Europe Polio Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Polio Vaccine Market Size by Country
8.2.1 Europe Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Polio Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Polio Vaccine Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Polio Vaccine Sales by Country
9.1.1 Asia-Pacific Polio Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Polio Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Polio Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Polio Vaccine Market Size by Country
9.2.1 Asia-Pacific Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Polio Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Polio Vaccine Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Polio Vaccine Sales by Country
10.1.1 Latin America Polio Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Polio Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Polio Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Polio Vaccine Market Size by Country
10.2.1 Latin America Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Polio Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Polio Vaccine Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Polio Vaccine Sales by Country
11.1.1 Middle East and Africa Polio Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Polio Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Polio Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Polio Vaccine Market Size by Country
11.2.1 Middle East and Africa Polio Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Polio Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Polio Vaccine Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Polio Vaccine Value Chain Analysis
12.1.1 Polio Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Polio Vaccine Production Mode & Process
12.2 Polio Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Polio Vaccine Distributors
12.2.3 Polio Vaccine Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Major Company of Inactivated Polio Vaccine (IPV)
Table 2. Major Company of Oral Polio Vaccine (OPV)
Table 3. Global Polio Vaccine Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Global Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 5. Global Polio Vaccine Sales Market Share in Volume by Type (2019-2024)
Table 6. Global Polio Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 7. Global Polio Vaccine Sales Market Share in Value by Type (2019-2024)
Table 8. Global Polio Vaccine Price by Type (2019-2024) & (USD/K Doses)
Table 9. Global Polio Vaccine Sales by Type (2025-2030) & (M Doses)
Table 10. Global Polio Vaccine Sales Market Share in Volume by Type (2025-2030)
Table 11. Global Polio Vaccine Sales by Type (2025-2030) & (US$ Million)
Table 12. Global Polio Vaccine Sales Market Share in Value by Type (2025-2030)
Table 13. Global Polio Vaccine Price by Type (2025-2030) & (USD/K Doses)
Table 14. North America Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 15. North America Polio Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 16. Europe Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 17. Europe Polio Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 18. Asia-Pacific Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 19. Asia-Pacific Polio Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 20. Latin America Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 21. Latin America Polio Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 22. Middle East and Africa Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 23. Middle East and Africa Polio Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 24. Polio Vaccine Industry Trends
Table 25. Polio Vaccine Industry Drivers
Table 26. Polio Vaccine Industry Opportunities and Challenges
Table 27. Polio Vaccine Industry Restraints
Table 28. Global Polio Vaccine Sales Revenue by Company (US$ Million) & (2019-2024)
Table 29. Global Polio Vaccine Revenue Market Share by Company (2019-2024)
Table 30. Global Polio Vaccine Sales by Company (2019-2024) & (M Doses)
Table 31. Global Polio Vaccine Sales Share by Company (2019-2024)
Table 32. Global Polio Vaccine Market Price by Company (2019-2024) & (USD/K Doses)
Table 33. Global Polio Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
Table 34. Global Polio Vaccine Key Company Manufacturing Sites & Headquarters
Table 35. Global Polio Vaccine Company, Product Type & Application
Table 36. Global Polio Vaccine Company Commercialization Time
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global Polio Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 39. Global Polio Vaccine Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Global Polio Vaccine Sales by Region (2019-2024) & (M Doses)
Table 41. Global Polio Vaccine Sales Market Share in Volume by Region (2019-2024)
Table 42. Global Polio Vaccine Sales by Region (2019-2024) & (US$ Million)
Table 43. Global Polio Vaccine Sales Market Share in Value by Region (2019-2024)
Table 44. Global Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 45. Global Polio Vaccine Sales by Region (2025-2030) & (M Doses)
Table 46. Global Polio Vaccine Sales Market Share in Volume by Region (2025-2030)
Table 47. Global Polio Vaccine Sales by Region (2025-2030) & (US$ Million)
Table 48. Global Polio Vaccine Sales Market Share in Value by Region (2025-2030)
Table 49. Global Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2025-2030)
Table 50. Global Polio Vaccine Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 51. Global Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 52. Global Polio Vaccine Sales Market Share in Volume by Application (2019-2024)
Table 53. Global Polio Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 54. Global Polio Vaccine Sales Market Share in Value by Application (2019-2024)
Table 55. Global Polio Vaccine Price by Application (2019-2024) & (USD/K Doses)
Table 56. Global Polio Vaccine Sales by Application (2025-2030) & (M Doses)
Table 57. Global Polio Vaccine Sales Market Share in Volume by Application (2025-2030)
Table 58. Global Polio Vaccine Sales by Application (2025-2030) & (US$ Million)
Table 59. Global Polio Vaccine Sales Market Share in Value by Application (2025-2030)
Table 60. Global Polio Vaccine Price by Application (2025-2030) & (USD/K Doses)
Table 61. North America Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 62. North America Polio Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 63. Europe Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 64. Europe Polio Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 65. Asia-Pacific Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 66. Asia-Pacific Polio Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 67. Latin America Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 68. Latin America Polio Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 69. Middle East and Africa Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 70. Middle East and Africa Polio Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 71. Sanofi Company Information
Table 72. Sanofi Business Overview
Table 73. Sanofi Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 74. Sanofi Polio Vaccine Product Portfolio
Table 75. Sanofi Recent Development
Table 76. GSK Company Information
Table 77. GSK Business Overview
Table 78. GSK Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 79. GSK Polio Vaccine Product Portfolio
Table 80. GSK Recent Development
Table 81. Bibcol Company Information
Table 82. Bibcol Business Overview
Table 83. Bibcol Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 84. Bibcol Polio Vaccine Product Portfolio
Table 85. Bibcol Recent Development
Table 86. Serum Institute Company Information
Table 87. Serum Institute Business Overview
Table 88. Serum Institute Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 89. Serum Institute Polio Vaccine Product Portfolio
Table 90. Serum Institute Recent Development
Table 91. Tiantan Biological Company Information
Table 92. Tiantan Biological Business Overview
Table 93. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 94. Tiantan Biological Polio Vaccine Product Portfolio
Table 95. Tiantan Biological Recent Development
Table 96. IMBCA Company Information
Table 97. IMBCA Business Overview
Table 98. IMBCA Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 99. IMBCA Polio Vaccine Product Portfolio
Table 100. IMBCA Recent Development
Table 101. Panacea Biotec Ltd Company Information
Table 102. Panacea Biotec Ltd Business Overview
Table 103. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 104. Panacea Biotec Ltd Polio Vaccine Product Portfolio
Table 105. Panacea Biotec Ltd Recent Development
Table 106. Bio-Med Company Information
Table 107. Bio-Med Business Overview
Table 108. Bio-Med Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 109. Bio-Med Polio Vaccine Product Portfolio
Table 110. Bio-Med Recent Development
Table 111. Halfkin Bio-Pharmaceuticals Company Information
Table 112. Halfkin Bio-Pharmaceuticals Business Overview
Table 113. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 114. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
Table 115. Halfkin Bio-Pharmaceuticals Recent Development
Table 116. North America Polio Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 117. North America Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 118. North America Polio Vaccine Sales Market Share by Country (2019-2024)
Table 119. North America Polio Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 120. North America Polio Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 121. North America Polio Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 122. North America Polio Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 123. North America Polio Vaccine Market Share by Country (2019-2024)
Table 124. North America Polio Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 125. North America Polio Vaccine Market Share Forecast by Country (2025-2030)
Table 126. Europe Polio Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 127. Europe Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 128. Europe Polio Vaccine Sales Market Share by Country (2019-2024)
Table 129. Europe Polio Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 130. Europe Polio Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 131. Europe Polio Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 132. Europe Polio Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 133. Europe Polio Vaccine Market Share by Country (2019-2024)
Table 134. Europe Polio Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 135. Europe Polio Vaccine Market Share Forecast by Country (2025-2030)
Table 136. Asia-Pacific Polio Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 137. Asia-Pacific Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 138. Asia-Pacific Polio Vaccine Sales Market Share by Country (2019-2024)
Table 139. Asia-Pacific Polio Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 140. Asia-Pacific Polio Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 141. Asia-Pacific Polio Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 142. Asia-Pacific Polio Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 143. Asia-Pacific Polio Vaccine Market Share by Country (2019-2024)
Table 144. Asia-Pacific Polio Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 145. Asia-Pacific Polio Vaccine Market Share Forecast by Country (2025-2030)
Table 146. Latin America Polio Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 147. Latin America Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 148. Latin America Polio Vaccine Sales Market Share by Country (2019-2024)
Table 149. Latin America Polio Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 150. Latin America Polio Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 151. Latin America Polio Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 152. Latin America Polio Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 153. Latin America Polio Vaccine Market Share by Country (2019-2024)
Table 154. Latin America Polio Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 155. Latin America Polio Vaccine Market Share Forecast by Country (2025-2030)
Table 156. Middle East and Africa Polio Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 157. Middle East and Africa Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 158. Middle East and Africa Polio Vaccine Sales Market Share by Country (2019-2024)
Table 159. Middle East and Africa Polio Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 160. Middle East and Africa Polio Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 161. Middle East and Africa Polio Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 162. Middle East and Africa Polio Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 163. Middle East and Africa Polio Vaccine Market Share by Country (2019-2024)
Table 164. Middle East and Africa Polio Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 165. Middle East and Africa Polio Vaccine Market Share Forecast by Country (2025-2030)
Table 166. Key Raw Materials
Table 167. Raw Materials Key Suppliers
Table 168. Polio Vaccine Distributors List
Table 169. Polio Vaccine Customers List
Table 170. Research Programs/Design for This Report
Table 171. Authors List of This Report
Table 172. Secondary Sources
Table 173. Primary Sources
Table 1. Major Company of Inactivated Polio Vaccine (IPV)
Table 2. Major Company of Oral Polio Vaccine (OPV)
Table 3. Global Polio Vaccine Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Global Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 5. Global Polio Vaccine Sales Market Share in Volume by Type (2019-2024)
Table 6. Global Polio Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 7. Global Polio Vaccine Sales Market Share in Value by Type (2019-2024)
Table 8. Global Polio Vaccine Price by Type (2019-2024) & (USD/K Doses)
Table 9. Global Polio Vaccine Sales by Type (2025-2030) & (M Doses)
Table 10. Global Polio Vaccine Sales Market Share in Volume by Type (2025-2030)
Table 11. Global Polio Vaccine Sales by Type (2025-2030) & (US$ Million)
Table 12. Global Polio Vaccine Sales Market Share in Value by Type (2025-2030)
Table 13. Global Polio Vaccine Price by Type (2025-2030) & (USD/K Doses)
Table 14. North America Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 15. North America Polio Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 16. Europe Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 17. Europe Polio Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 18. Asia-Pacific Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 19. Asia-Pacific Polio Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 20. Latin America Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 21. Latin America Polio Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 22. Middle East and Africa Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 23. Middle East and Africa Polio Vaccine Sales by Type (2019-2024) & (US$ Million)
Table 24. Polio Vaccine Industry Trends
Table 25. Polio Vaccine Industry Drivers
Table 26. Polio Vaccine Industry Opportunities and Challenges
Table 27. Polio Vaccine Industry Restraints
Table 28. Global Polio Vaccine Sales Revenue by Company (US$ Million) & (2019-2024)
Table 29. Global Polio Vaccine Revenue Market Share by Company (2019-2024)
Table 30. Global Polio Vaccine Sales by Company (2019-2024) & (M Doses)
Table 31. Global Polio Vaccine Sales Share by Company (2019-2024)
Table 32. Global Polio Vaccine Market Price by Company (2019-2024) & (USD/K Doses)
Table 33. Global Polio Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
Table 34. Global Polio Vaccine Key Company Manufacturing Sites & Headquarters
Table 35. Global Polio Vaccine Company, Product Type & Application
Table 36. Global Polio Vaccine Company Commercialization Time
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global Polio Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 39. Global Polio Vaccine Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Global Polio Vaccine Sales by Region (2019-2024) & (M Doses)
Table 41. Global Polio Vaccine Sales Market Share in Volume by Region (2019-2024)
Table 42. Global Polio Vaccine Sales by Region (2019-2024) & (US$ Million)
Table 43. Global Polio Vaccine Sales Market Share in Value by Region (2019-2024)
Table 44. Global Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 45. Global Polio Vaccine Sales by Region (2025-2030) & (M Doses)
Table 46. Global Polio Vaccine Sales Market Share in Volume by Region (2025-2030)
Table 47. Global Polio Vaccine Sales by Region (2025-2030) & (US$ Million)
Table 48. Global Polio Vaccine Sales Market Share in Value by Region (2025-2030)
Table 49. Global Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2025-2030)
Table 50. Global Polio Vaccine Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 51. Global Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 52. Global Polio Vaccine Sales Market Share in Volume by Application (2019-2024)
Table 53. Global Polio Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 54. Global Polio Vaccine Sales Market Share in Value by Application (2019-2024)
Table 55. Global Polio Vaccine Price by Application (2019-2024) & (USD/K Doses)
Table 56. Global Polio Vaccine Sales by Application (2025-2030) & (M Doses)
Table 57. Global Polio Vaccine Sales Market Share in Volume by Application (2025-2030)
Table 58. Global Polio Vaccine Sales by Application (2025-2030) & (US$ Million)
Table 59. Global Polio Vaccine Sales Market Share in Value by Application (2025-2030)
Table 60. Global Polio Vaccine Price by Application (2025-2030) & (USD/K Doses)
Table 61. North America Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 62. North America Polio Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 63. Europe Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 64. Europe Polio Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 65. Asia-Pacific Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 66. Asia-Pacific Polio Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 67. Latin America Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 68. Latin America Polio Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 69. Middle East and Africa Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 70. Middle East and Africa Polio Vaccine Sales by Application (2019-2024) & (US$ Million)
Table 71. Sanofi Company Information
Table 72. Sanofi Business Overview
Table 73. Sanofi Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 74. Sanofi Polio Vaccine Product Portfolio
Table 75. Sanofi Recent Development
Table 76. GSK Company Information
Table 77. GSK Business Overview
Table 78. GSK Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 79. GSK Polio Vaccine Product Portfolio
Table 80. GSK Recent Development
Table 81. Bibcol Company Information
Table 82. Bibcol Business Overview
Table 83. Bibcol Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 84. Bibcol Polio Vaccine Product Portfolio
Table 85. Bibcol Recent Development
Table 86. Serum Institute Company Information
Table 87. Serum Institute Business Overview
Table 88. Serum Institute Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 89. Serum Institute Polio Vaccine Product Portfolio
Table 90. Serum Institute Recent Development
Table 91. Tiantan Biological Company Information
Table 92. Tiantan Biological Business Overview
Table 93. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 94. Tiantan Biological Polio Vaccine Product Portfolio
Table 95. Tiantan Biological Recent Development
Table 96. IMBCA Company Information
Table 97. IMBCA Business Overview
Table 98. IMBCA Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 99. IMBCA Polio Vaccine Product Portfolio
Table 100. IMBCA Recent Development
Table 101. Panacea Biotec Ltd Company Information
Table 102. Panacea Biotec Ltd Business Overview
Table 103. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 104. Panacea Biotec Ltd Polio Vaccine Product Portfolio
Table 105. Panacea Biotec Ltd Recent Development
Table 106. Bio-Med Company Information
Table 107. Bio-Med Business Overview
Table 108. Bio-Med Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 109. Bio-Med Polio Vaccine Product Portfolio
Table 110. Bio-Med Recent Development
Table 111. Halfkin Bio-Pharmaceuticals Company Information
Table 112. Halfkin Bio-Pharmaceuticals Business Overview
Table 113. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 114. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
Table 115. Halfkin Bio-Pharmaceuticals Recent Development
Table 116. North America Polio Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 117. North America Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 118. North America Polio Vaccine Sales Market Share by Country (2019-2024)
Table 119. North America Polio Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 120. North America Polio Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 121. North America Polio Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 122. North America Polio Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 123. North America Polio Vaccine Market Share by Country (2019-2024)
Table 124. North America Polio Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 125. North America Polio Vaccine Market Share Forecast by Country (2025-2030)
Table 126. Europe Polio Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 127. Europe Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 128. Europe Polio Vaccine Sales Market Share by Country (2019-2024)
Table 129. Europe Polio Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 130. Europe Polio Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 131. Europe Polio Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 132. Europe Polio Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 133. Europe Polio Vaccine Market Share by Country (2019-2024)
Table 134. Europe Polio Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 135. Europe Polio Vaccine Market Share Forecast by Country (2025-2030)
Table 136. Asia-Pacific Polio Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 137. Asia-Pacific Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 138. Asia-Pacific Polio Vaccine Sales Market Share by Country (2019-2024)
Table 139. Asia-Pacific Polio Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 140. Asia-Pacific Polio Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 141. Asia-Pacific Polio Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 142. Asia-Pacific Polio Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 143. Asia-Pacific Polio Vaccine Market Share by Country (2019-2024)
Table 144. Asia-Pacific Polio Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 145. Asia-Pacific Polio Vaccine Market Share Forecast by Country (2025-2030)
Table 146. Latin America Polio Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 147. Latin America Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 148. Latin America Polio Vaccine Sales Market Share by Country (2019-2024)
Table 149. Latin America Polio Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 150. Latin America Polio Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 151. Latin America Polio Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 152. Latin America Polio Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 153. Latin America Polio Vaccine Market Share by Country (2019-2024)
Table 154. Latin America Polio Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 155. Latin America Polio Vaccine Market Share Forecast by Country (2025-2030)
Table 156. Middle East and Africa Polio Vaccine Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 157. Middle East and Africa Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 158. Middle East and Africa Polio Vaccine Sales Market Share by Country (2019-2024)
Table 159. Middle East and Africa Polio Vaccine Sales Forecast by Country (2025-2030) & (M Doses)
Table 160. Middle East and Africa Polio Vaccine Sales Market Share Forecast by Country (2025-2030)
Table 161. Middle East and Africa Polio Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 162. Middle East and Africa Polio Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 163. Middle East and Africa Polio Vaccine Market Share by Country (2019-2024)
Table 164. Middle East and Africa Polio Vaccine Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 165. Middle East and Africa Polio Vaccine Market Share Forecast by Country (2025-2030)
Table 166. Key Raw Materials
Table 167. Raw Materials Key Suppliers
Table 168. Polio Vaccine Distributors List
Table 169. Polio Vaccine Customers List
Table 170. Research Programs/Design for This Report
Table 171. Authors List of This Report
Table 172. Secondary Sources
Table 173. Primary Sources
LIST OF FIGURES
Figure 1. Polio Vaccine Product Picture
Figure 2. Global Polio Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Polio Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Polio Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Product Picture of Inactivated Polio Vaccine (IPV)
Figure 6. Global Inactivated Polio Vaccine (IPV) Sales YoY Growth (2019-2030) & (M Doses)
Figure 7. Product Picture of Oral Polio Vaccine (OPV)
Figure 8. Global Oral Polio Vaccine (OPV) Sales YoY Growth (2019-2030) & (M Doses)
Figure 9. Global Polio Vaccine Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 10. Global Polio Vaccine Market Share by Type 2023 VS 2030
Figure 11. North America Polio Vaccine Sales Market Share in Volume by Type in 2023
Figure 12. North America Polio Vaccine Sales Market Share in Value by Type in 2023
Figure 13. Europe Polio Vaccine Sales Market Share in Volume by Type in 2023
Figure 14. Europe Polio Vaccine Sales Market Share in Value by Type in 2023
Figure 15. Asia-Pacific Polio Vaccine Sales Market Share in Volume by Type in 2023
Figure 16. Asia-Pacific Polio Vaccine Sales Market Share in Value by Type in 2023
Figure 17. Latin America Polio Vaccine Sales Market Share in Volume by Type in 2023
Figure 18. Latin America Polio Vaccine Sales Market Share in Value by Type in 2023
Figure 19. Middle East and Africa Polio Vaccine Sales Market Share in Volume by Type in 2023
Figure 20. Middle East and Africa Polio Vaccine Sales Market Share in Value by Type in 2023
Figure 21. Global Top 5 and 10 Polio Vaccine Players Market Share by Revenue in 2023
Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Product Picture of Public
Figure 24. Global Public Sales YoY Growth (2019-2030) & (M Doses)
Figure 25. Product Picture of Private
Figure 26. Global Private Sales YoY Growth (2019-2030) & (M Doses)
Figure 27. Global Polio Vaccine Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 28. Global Polio Vaccine Market Share by Application 2023 VS 2030
Figure 29. North America Polio Vaccine Sales Market Share in Volume by Application in 2023
Figure 30. North America Polio Vaccine Sales Market Share in Value by Application in 2023
Figure 31. Europe Polio Vaccine Sales Market Share in Volume by Application in 2023
Figure 32. Europe Polio Vaccine Sales Market Share in Value by Application in 2023
Figure 33. Asia-Pacific Polio Vaccine Sales Market Share in Volume by Application in 2023
Figure 34. Asia-Pacific Polio Vaccine Sales Market Share in Value by Application in 2023
Figure 35. Latin America Polio Vaccine Sales Market Share in Volume by Application in 2023
Figure 36. Latin America Polio Vaccine Sales Market Share in Value by Application in 2023
Figure 37. Middle East and Africa Polio Vaccine Sales Market Share in Volume by Application in 2023
Figure 38. Middle East and Africa Polio Vaccine Sales Market Share in Value by Application in 2023
Figure 39. North America Polio Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 40. North America Polio Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 41. North America Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 42. North America Polio Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 43. Europe Polio Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 44. Europe Polio Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 45. Europe Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 46. Europe Polio Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 47. Asia-Pacific Polio Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 48. Asia-Pacific Polio Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 50. Asia-Pacific Polio Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 51. Latin America Polio Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 52. Latin America Polio Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 53. Latin America Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Latin America Polio Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 55. Middle East and Africa Polio Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 56. Middle East and Africa Polio Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 57. Middle East and Africa Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 58. Middle East and Africa Polio Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 59. Polio Vaccine Value Chain
Figure 60. Key Raw Materials Price
Figure 61. Manufacturing Cost Structure
Figure 62. Polio Vaccine Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
Figure 1. Polio Vaccine Product Picture
Figure 2. Global Polio Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Polio Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Polio Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Product Picture of Inactivated Polio Vaccine (IPV)
Figure 6. Global Inactivated Polio Vaccine (IPV) Sales YoY Growth (2019-2030) & (M Doses)
Figure 7. Product Picture of Oral Polio Vaccine (OPV)
Figure 8. Global Oral Polio Vaccine (OPV) Sales YoY Growth (2019-2030) & (M Doses)
Figure 9. Global Polio Vaccine Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 10. Global Polio Vaccine Market Share by Type 2023 VS 2030
Figure 11. North America Polio Vaccine Sales Market Share in Volume by Type in 2023
Figure 12. North America Polio Vaccine Sales Market Share in Value by Type in 2023
Figure 13. Europe Polio Vaccine Sales Market Share in Volume by Type in 2023
Figure 14. Europe Polio Vaccine Sales Market Share in Value by Type in 2023
Figure 15. Asia-Pacific Polio Vaccine Sales Market Share in Volume by Type in 2023
Figure 16. Asia-Pacific Polio Vaccine Sales Market Share in Value by Type in 2023
Figure 17. Latin America Polio Vaccine Sales Market Share in Volume by Type in 2023
Figure 18. Latin America Polio Vaccine Sales Market Share in Value by Type in 2023
Figure 19. Middle East and Africa Polio Vaccine Sales Market Share in Volume by Type in 2023
Figure 20. Middle East and Africa Polio Vaccine Sales Market Share in Value by Type in 2023
Figure 21. Global Top 5 and 10 Polio Vaccine Players Market Share by Revenue in 2023
Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Product Picture of Public
Figure 24. Global Public Sales YoY Growth (2019-2030) & (M Doses)
Figure 25. Product Picture of Private
Figure 26. Global Private Sales YoY Growth (2019-2030) & (M Doses)
Figure 27. Global Polio Vaccine Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 28. Global Polio Vaccine Market Share by Application 2023 VS 2030
Figure 29. North America Polio Vaccine Sales Market Share in Volume by Application in 2023
Figure 30. North America Polio Vaccine Sales Market Share in Value by Application in 2023
Figure 31. Europe Polio Vaccine Sales Market Share in Volume by Application in 2023
Figure 32. Europe Polio Vaccine Sales Market Share in Value by Application in 2023
Figure 33. Asia-Pacific Polio Vaccine Sales Market Share in Volume by Application in 2023
Figure 34. Asia-Pacific Polio Vaccine Sales Market Share in Value by Application in 2023
Figure 35. Latin America Polio Vaccine Sales Market Share in Volume by Application in 2023
Figure 36. Latin America Polio Vaccine Sales Market Share in Value by Application in 2023
Figure 37. Middle East and Africa Polio Vaccine Sales Market Share in Volume by Application in 2023
Figure 38. Middle East and Africa Polio Vaccine Sales Market Share in Value by Application in 2023
Figure 39. North America Polio Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 40. North America Polio Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 41. North America Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 42. North America Polio Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 43. Europe Polio Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 44. Europe Polio Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 45. Europe Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 46. Europe Polio Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 47. Asia-Pacific Polio Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 48. Asia-Pacific Polio Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 50. Asia-Pacific Polio Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 51. Latin America Polio Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 52. Latin America Polio Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 53. Latin America Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Latin America Polio Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 55. Middle East and Africa Polio Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 56. Middle East and Africa Polio Vaccine Sales Share by Country: 2019 VS 2023 VS 2030
Figure 57. Middle East and Africa Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 58. Middle East and Africa Polio Vaccine Market Share by Country: 2019 VS 2023 VS 2030
Figure 59. Polio Vaccine Value Chain
Figure 60. Key Raw Materials Price
Figure 61. Manufacturing Cost Structure
Figure 62. Polio Vaccine Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
